Uracil-specific anti-R.N.A. antibodies in scleroderma

Area of Science:

• Immunology
• Rheumatology
• Molecular Biology

Background:

• Autoantibodies are crucial biomarkers in autoimmune diseases like scleroderma and systemic lupus erythematosus (SLE).
• Previous research has identified various autoantibodies in these conditions, but the specificities against nucleic acids require further elucidation.

Purpose of the Study:

• To investigate the presence and characteristics of antibodies to single-stranded ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) in patients with scleroderma.
• To differentiate immunochemically the autoantibodies found in scleroderma from those in SLE.

Main Methods:

• Counter immunoelectrophoresis was employed to detect antibodies in patient sera.
• Immunochemical methods were used to characterize the specificity of the antibodies against RNA and DNA bases.

Main Results:

• All 40 scleroderma sera tested positive for antibodies to single-stranded RNA, specifically reacting with uracil bases.
• Antibodies to RNA were found in 20 of 40 SLE sera and none of the controls.
• RNA antibodies in SLE sera were more heterogeneous and reacted selectively with uridine or uridine monophosphate, differing from scleroderma antibodies.
• Antibodies to DNA were more frequent in SLE than in scleroderma.
• Ten of 18 scleroderma sera reacting with DNA also reacted with thymidine, confirming the presence of anti-DNA antibodies and ruling out cross-reactivity with anti-RNA antibodies.

Conclusions:

• Single-stranded RNA antibodies, specific to uracil, are consistently present in scleroderma patients.
• Distinct immunochemical profiles of RNA antibodies exist between scleroderma and SLE.
• The study confirms the presence of DNA antibodies in scleroderma, differentiating them from RNA antibodies.